Medication info

Omapeoneperi Injection

Prescription medicationInjectionsInjection
Ingredient · strength
L-Alanine›1.4gL-Arginine›1.2gGlycine›1.1gL-Histidine›0.3gL-Isoleucine›0.5gL-Leucine›0.74gL-Lysine Acetate›0.93gL-Methionine›0.43gL-Phenylalanine›0.51gL-Proline›1.12gL-Serine›0.65gTaurine›0.1gL-Threonine›0.44gL-Tryptophan›0.2gL-Tyrosine›0.04gL-Valine›0.62gCalcium Chloride Hydrate›0.074gAnhydrous Sodium Glycerophosphate›0.418gMagnesium Sulfate Heptahydrate›0.247gPotassium Chloride›0.448gSodium Acetate Hydrate›0.562gZinc Sulfate Heptahydrate›0.0023gGlucose Monohydrate›14.3gSoybean Oil›6gTriglycerides Medium-Chain›6gPurified Olive Oil›5gPurified Fish Oil (High Dose Omega-3 Fatty Acids)›3g
Manufacturer / importer
HK inno.N Co., Ltd.
Appearance
It consists of a plastic bag for injection that is transparent and colorless, divided into three compartments, with an oxygen absorber placed between them. Each inner bag contains a transparent amino acid solution that is colorless to pale yellow.
Packaging
362mL (Component A: 114mL, Component B: 197mL, Component C: 51mL), 500mL (Component A: 157.5mL, Component B: 272mL, Component C: 70.5mL), 660mL (Component A: 208mL, Component B: 359mL, Component C: 93mL), 724mL (Component A: 228mL, Component B: 394mL, Component C: 102mL), 952mL (Component A: 300mL, Component B: 51
Approval status
Active

MFDS item code 201500951 · Notified 2015.02.24 · Insurance code 640006710,640006830,640006840,640006850,

Summary

Main use
Correction of inadequate nutrient supply through parenteral nutrition (calories, amino acids, fatty acids, etc.)
Who receives it
Adults · Children
Adult administration
The dose and infusion rate are determined according to the patient's ability to clear fat and metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized in consideration of the patient's condition, body weight, nutritional and energy requirements, and additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. Nitrogen requirements for maintaining body protein depend on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children aged 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: amino acids 0.6-0.9 g/kg per day (nitrogen 0.10-0.15 g/kg) - Patients experiencing moderate to high metabolic stress, regardless of nutritional imbalance: amino acids 0.9-1.6 g/kg per day (nitrogen 0.15-0.25 g/kg) In very special cases (e.g., burns or pronounced anabolic states), nitrogen requirements may be higher. Dose A daily dose of 20-40 mL/kg of this medicine provides amino acids 0.6-1.3 g/kg (nitrogen 0.10-0.20 g/kg) and total calories 14-28 kcal/kg (non-protein calories 11-22 kcal/kg)). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides amino acids1.3 g/kg (nitrogen 0.20 g/kg), glucose 2.8g/kg, fat 1.1g/kg, and total calories 28 kcal/kg (equivalent to non-protein calories 22 kcal/kg). Administration Administer by intravenous infusion through a peripheral or central vein.
Child administration
Children aged 2-11 years: Regularly adjust the dose according to requirements, up to 40 mL/kg of this medicine per day. The recommended maximum daily dose is 40mL/kg, providing amino acids 1.3 g/kg (nitrogen 0.2 g/kg), glucose 2.8 g/kg, fat 1.1 g/kg, and total calories 28 kcal/kg (equivalent to non-protein calories 22 kcal/kg). The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 12-24 hours. When administering the recommended maximum daily dose, the infusion should be given over at least 13 hours, except in special circumstances.

Ingredients

Manufacturer
HK inno.N Co., Ltd.

Efficacy & effects

Correction of inadequate nutrient supply through parenteral nutrition (calories, amino acids, fatty acids, etc.)

View approved original text

This medication is used to provide necessary calories, amino acids, essential fatty acids, and omega-3 fatty acids for children over 2 years of age and adults when oral intake or nutritional supply via the gastrointestinal tract is difficult. It helps patients maintain adequate nutrition and improves energy and nutrient deficiencies.

How it is given

Adult administration

The dose and infusion rate are determined according to the patient's ability to clear fat and metabolize nitrogen and glucose, and nutritional requirements. The dose should be individualized in consideration of the patient's condition, body weight, nutritional and energy requirements, and additional oral/enteral intake. Trace elements, vitamins, electrolytes, etc. may be added depending on the patient's condition. Nitrogen requirements for maintaining body protein depend on the patient's condition (e.g., nutritional status and catabolic stress or anabolism). Children aged 12 years and older and adults - Patients with normal nutritional status or mild metabolic stress: amino acids 0.6-0.9 g/kg per day (nitrogen 0.10-0.15 g/kg) - Patients experiencing moderate to high metabolic stress, regardless of nutritional imbalance: amino acids 0.9-1.6 g/kg per day (nitrogen 0.15-0.25 g/kg) In very special cases (e.g., burns or pronounced anabolic states), nitrogen requirements may be higher. Dose A daily dose of 20-40 mL/kg of this medicine provides amino acids 0.6-1.3 g/kg (nitrogen 0.10-0.20 g/kg) and total calories 14-28 kcal/kg (non-protein calories 11-22 kcal/kg)). This meets the requirements of most patients. In obese patients, the dose should be based on predicted normal body weight. Infusion rate The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 14-24 hours. Maximum daily dose The maximum daily dose depends on the patient's clinical condition and may vary from day to day. The recommended maximum daily dose is 40mL/kg. The recommended maximum daily dose of 40mL/kg provides amino acids1.3 g/kg (nitrogen 0.20 g/kg), glucose 2.8g/kg, fat 1.1g/kg, and total calories 28 kcal/kg (equivalent to non-protein calories 22 kcal/kg). Administration Administer by intravenous infusion through a peripheral or central vein.

Child administration

Children aged 2-11 years: Regularly adjust the dose according to requirements, up to 40 mL/kg of this medicine per day. The recommended maximum daily dose is 40mL/kg, providing amino acids 1.3 g/kg (nitrogen 0.2 g/kg), glucose 2.8 g/kg, fat 1.1 g/kg, and total calories 28 kcal/kg (equivalent to non-protein calories 22 kcal/kg). The infusion rate should not exceed 3.0 mL/kg per hour (equivalent to amino acids 0.10 g/kg, glucose 0.21 g/kg, and fat 0.08 g/kg). The recommended infusion duration is 12-24 hours. When administering the recommended maximum daily dose, the infusion should be given over at least 13 hours, except in special circumstances.

Precautions

This medication must be used under the direction of a physician. If symptoms of anaphylactic reaction occur, such as fever, chills, rash, or difficulty breathing, administration should be discontinued immediately. When used in conjunction with intravenous calcium-containing preparations, precipitates may form if mixed with Ceftriaxone, so the same infusion device should not be used simultaneously, and the infusion line should be cleaned before and after infusion. Use with caution in premature or low-birth-weight infants as it may cause an increase in plasma free fatty acid levels, which can be especially risky in premature infants with severe respiratory disease. Do not administer to patients with hypersensitivity to fish, eggs, soybeans, peanuts, or those with severe hyperlipidemia, liver dysfunction, blood coagulation disorders, renal failure, acute shock, or uncontrolled hyperglycemia. Exercise caution in states that may affect lipid metabolism such as renal failure, diabetes, liver dysfunction, and sepsis. During administration, blood triglyceride levels should be monitored periodically to prevent hyperlipidemia syndrome from excessive dosing. Excessive doses of amino acids and glucose may cause side effects such as nausea, vomiting, and hyperglycemia, so the recommended doses and rates should be adhered to. This medication contains soybean oil, fish oil, and egg yolk phospholipids, which may rarely cause allergic reactions, so patients with a history of allergies should exercise caution. Strict aseptic procedures must be followed before and after administration to prevent infections, and signs of thrombophlebitis at the administration site should be monitored frequently. The safety of this medication has not been established in pregnant or breastfeeding women, and it should only be used if the therapeutic benefit outweighs the risks. In cases of overdose, the infusion rate should be slowed or stopped, and appropriate treatment such as insulin administration or dialysis should be pursued if necessary. This medication should be stored below 25 degrees Celsius and should be used immediately after mixing, or if refrigerated, within 24 hours.

Side effects

  • fever
  • chills
  • rash
  • dyspnea
  • tachycardia
  • anorexia
  • nausea
  • vomiting
  • increased plasma enzyme levels
  • thrombophlebitis
Show 115 more
  • hypotension
  • hypertension
  • slight elevation of body temperature
  • headache
  • dizziness
  • anaphylactic or anaphylactoid reaction
  • skin rash
  • urticaria
  • flushing
  • warmth
  • cold sensation
  • cyanosis
  • pallor
  • pain (throat, back, bones, chest, waist)
  • hyperlipidemia
  • fever
  • fat infiltration
  • jaundice
  • hepatomegaly
  • splenomegaly
  • anemia
  • leukopenia
  • thrombocytopenia
  • coagulopathy
  • hemolysis
  • reticulocytosis
  • abnormal liver function test results
  • coma
  • nausea
  • vomiting
  • chills
  • sweating
  • elevated body temperature
  • hyperglycemia
  • allergic reaction
  • constipation
  • diarrhea
  • pneumonia
  • stomatitis
  • delirium
  • dyspepsia
  • abdominal pain
  • hypoalbuminemia
  • insomnia
  • febrile neutropenia
  • general weakness
  • edema
  • urination disorder
  • hematuria
  • weight loss
  • hypoglycemia
  • hypocalcemia
  • heartburn
  • aspiration pneumonia
  • hematemesis
  • rhinorrhea
  • extravasation at the injection site
  • phlebitis
  • procedure site reaction
  • dysuria
  • cough
  • infection
  • thromboembolism
  • bloody stools
  • vasculitis
  • skin infection
  • pulmonary edema
  • sepsis
  • Clostridium infection
  • candidiasis
  • dental disease
  • pancreatitis
  • weight gain
  • fluid overload
  • spinal compression
  • vaginal bleeding
  • interstitial fluid retention
  • hyponatremia
  • bowel obstruction
  • cervical cancer
  • gum bleeding
  • pharyngeal disease
  • depression
  • pressure ulcers
  • incontinence
  • urinary tract infection
  • malnutrition
  • laceration
  • gastroesophageal reflux disease
  • aspergillosis
  • oral thrush
  • neuropathic pain
  • neuropathy
  • esophagitis
  • vesicles
  • wound infection
  • upper abdominal pain
  • frequent urination
  • anxiety
  • ascites
  • abdominal discomfort
  • atelectasis
  • peripheral neuropathy
  • hiccups
  • colitis
  • leg edema
  • cerebral ischemia
  • acute renal failure
  • myalgia
  • hypersensitivity
  • worsening hypertension
  • conjunctival hemorrhage
  • hemoptysis
  • sputum disease
  • speech disorder

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air ingress, and it is important to keep it cool at temperatures below 25 degrees Celsius without freezing. This will help maintain the drug's efficacy and ensure safe usage.

Appearance and packaging

Appearance

It consists of a plastic bag for injection that is transparent and colorless, divided into three compartments, with an oxygen absorber placed between them. Each inner bag contains a transparent amino acid solution that is colorless to pale yellow.

Package unit

362mL (Component A: 114mL, Component B: 197mL, Component C: 51mL), 500mL (Component A: 157.5mL, Component B: 272mL, Component C: 70.5mL), 660mL (Component A: 208mL, Component B: 359mL, Component C: 93mL), 724mL (Component A: 228mL, Component B: 394mL, Component C: 102mL), 952mL (Component A: 300mL, Component B: 51

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.